Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at Truist Securities
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $55.53 +1.52%
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Truist Securities raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $66.00 (from $65.00) while maintaining a Hold rating.
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- Delta Air Lines (DAL) PT Raised to $107 at UBS Ahead of Q2 Results
- Globe Life (GL) PT Raised to $215 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
